Pregnane X receptor activation constrains mucosal NF-κB activity in active inflammatory bowel disease
Pregnane X receptor activation constrains mucosal NF-κB activity in active inflammatory bowel disease
复制标题
DOI:
10.1371/journal.pone.0221924
复制
发表时间:
2019-10-03
期刊:
影响因子:
3.7
通讯作者:
Peppelenbosch, Maikel
中科院分区:
文献类型:
--
作者:
Deuring, J. Jasper;Li, Meng;Peppelenbosch, Maikel
BackgroundThe Pregnane X Receptor (PXR) is a principal signal transducer in mucosal responses to xenobiotic stress. It is well-recognized that inflammatory bowel disease is accompanied by xenobiotic stress, but the importance of the PXR in limiting inflammatory responses in inflammatory bowel disease remains obscure at best.MethodsWe stimulate a total of 106 colonic biopsies from 19 Crohn's disease patients with active disease, 36 colonic biopsies from 8 control patients, colonic organoids and various cell culture models (either proficient or genetically deficient with respect to PXR) in vitro with the PXR ligand rifampicin or vehicle. Effects on NF-kappa B activity are assessed by measuring interleukin-8 (IL-8) and interleukin-1 beta (IL-1 beta) mRNA levels by qPCR and in cell culture models by NF-kappa B reporter-driven luciferase activity and Western blot for signal transduction elements.ResultsWe observe a strict inverse correlation between colonic epithelial PXR levels and NF-kappa B target gene expression in colonic biopsies from Crohn's disease patients. PXR, activated by rifampicin, is rate-limiting for mucosal NF-kappa B activation in IBD. The correlation between colonic epithelial PXR levels and NF-kappa B target gene expression was also observed in intestinal organoids system. Furthermore, in preclinical in vitro models of intestinal inflammation, including intestinal organoids, genetic inactivation of PXR unleashes NF-kappa B-dependent signal transduction whereas conversely NF-kappa B signaling reduces levels of PXR expression.ConclusionsOur data indicate that the PXR is a major and clinically relevant antagonist of NF-kappa B activity in the intestinal epithelial compartment during inflammatory bowel disease.